These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 27844106)

  • 1. Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodies.
    England CG; Rui L; Cai W
    Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):517-532. PubMed ID: 27844106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives of molecular imaging and radioimmunotherapy in lymphoma.
    Iagaru A; Goris ML; Gambhir SS
    Radiol Clin North Am; 2008 Mar; 46(2):243-52, viii. PubMed ID: 18619379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nuclear medicine and lymphoma].
    Fernández de Sevilla Ribosa A
    Rev Esp Med Nucl; 2006; 25(2):77-9. PubMed ID: 16759612
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of non-Hodgkin's lymphoma (NHL) with radiolabeled antibodies (mAbs).
    DeNardo GL
    Semin Nucl Med; 2005 Jul; 35(3):202-11. PubMed ID: 16098294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 90Y-ibritumomab tiuxetan as consolidation therapy after autologous stem cell transplantation in aggressive non-Hodgkin lymphoma.
    Ria R; Musto P; Reale A; Guariglia R; Iodice G; Dammacco F; Vacca A
    J Nucl Med; 2011 Jun; 52(6):891-5. PubMed ID: 21571787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioligand Therapy in Lymphoma: Past, Present, and Future.
    Almeida LS; Delgado Bolton RC; Heringer VC; de Souza Medina S; Etchebehere E
    PET Clin; 2024 Oct; 19(4):475-494. PubMed ID: 38969564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of immunoPET in receptor targeted cancer therapy.
    Marik J; Junutula JR
    Curr Drug Deliv; 2011 Jan; 8(1):70-8. PubMed ID: 21034420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunotherapy of acquired immunodeficiency syndrome (AIDS) associated lymphoma.
    O'Donnell RT; Leigh BR; Christensen SD; Goldstein DS; Kukis DL; Shen S; Yuan A; DeNardo DA; Kroger LA; DeNardo GL
    Cancer Biother Radiopharm; 1999 Jun; 14(3):167-76. PubMed ID: 10850301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in immuno-positron emission tomography: antibodies for molecular imaging in oncology.
    Knowles SM; Wu AM
    J Clin Oncol; 2012 Nov; 30(31):3884-92. PubMed ID: 22987087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The promise of immuno-PET in radioimmunotherapy.
    Verel I; Visser GW; van Dongen GA
    J Nucl Med; 2005 Jan; 46 Suppl 1():164S-71S. PubMed ID: 15653665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of response to fractionated radioimmunotherapy with 90Y-epratuzumab in non-Hodgkin's lymphoma by 18F-fluorodeoxyglucose positron emission tomography.
    Bodet-Milin C; Kraeber-Bodéré F; Dupas B; Morschhauser F; Gastinne T; Le Gouill S; Campion L; Harousseau JL; Wegener WA; Goldenberg DM; Huglo D
    Haematologica; 2008 Mar; 93(3):390-7. PubMed ID: 18268287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma.
    Sharkey RM; Karacay H; Johnson CR; Litwin S; Rossi EA; McBride WJ; Chang CH; Goldenberg DM
    J Nucl Med; 2009 Mar; 50(3):444-53. PubMed ID: 19223402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radioimmunotargeting: diagnosis and therapeutic use].
    Vuillez JP
    Bull Cancer; 2000 Nov; 87(11):813-27. PubMed ID: 11125290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monoclonal antibody treatment of malignant lymphoma].
    Buske C; Dreyling M; Unterhalt M; Hiddemann W
    Internist (Berl); 2004 Dec; 45(12):1370-7. PubMed ID: 15517123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.
    Rylova SN; Del Pozzo L; Klingeberg C; Tönnesmann R; Illert AL; Meyer PT; Maecke HR; Holland JP
    J Nucl Med; 2016 Jan; 57(1):96-102. PubMed ID: 26514172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunotherapy of non-Hodgkin's lymphoma: molecular targeting and novel agents.
    Pauwels EK; Erba P
    Drug News Perspect; 2007 Mar; 20(2):87-93. PubMed ID: 17440631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cure of incurable lymphoma.
    DeNardo GL; Sysko VV; DeNardo SJ
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S46-56. PubMed ID: 16979440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunotherapy for non-Hodgkin's lymphoma.
    Liebenguth P; Vogt Temple S
    Semin Oncol Nurs; 2006 Nov; 22(4):257-66. PubMed ID: 17095402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET Imaging of Lung Cancers in Precision Medicine: Current Landscape and Future Perspective.
    Wang Q; Zhang X; Wei W; Cao M
    Mol Pharm; 2022 Oct; 19(10):3471-3483. PubMed ID: 35771950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the mechanisms of action of radioimmunotherapy in lymphoma.
    Ivanov A; Swann R; Illidge T
    J Pharm Pharmacol; 2008 Aug; 60(8):987-98. PubMed ID: 18644192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.